{"accessLevel": "public", "bureauCode": ["020:00"], "contactPoint": {"fn": "Jonathan Haselman", "hasEmail": "mailto:haselman.jon@epa.gov"}, "description": "These data are represented in tables and graphs in the article, \"Targeted pathway-based in vivo testing using thyroperoxidase inhibition to evaluate plasma thyroxine as a surrogate metric of metamorphic success in model amphibian Xenopus laevis\" by JT Haselman et al. \n\nThis dataset is associated with the following publication:\nHaselman, J., J. Olker, P. Kosian, J. Korte, J. Swintek, J. Denny, J. Nichols, J. Tietge, M. Hornung, and S. Degitz. Targeted pathway-based in vivo testing using thyroperoxidase inhibition to evaluate plasma thyroxine as a surrogate metric of metamorphic success in model amphibian Xenopus laevis.   TOXICOLOGICAL SCIENCES. Society of Toxicology, RESTON, VA,  175(2): 236-250, (2020).", "distribution": [{"downloadURL": "https://pasteur.epa.gov/uploads/10.23719/1504195/Haselman_et_al_2019_data_SciHub.xlsx", "mediaType": "application/vnd.openxmlformats-officedocument.spreadsheetml.sheet", "title": "Haselman_et_al_2019_data_SciHub.xlsx"}], "identifier": "https://doi.org/10.23719/1504195", "keyword": ["thyroid", "adverse outcome pathway", "Xenopus laevis", "Thyroperoxidase"], "license": "https://pasteur.epa.gov/license/sciencehub-license.html", "modified": "2019-08-21", "programCode": ["020:095"], "publisher": {"name": "U.S. EPA Office of Research and Development (ORD)", "subOrganizationOf": {"name": "U.S. Environmental Protection Agency", "subOrganizationOf": {"name": "U.S. Government"}}}, "references": ["https://doi.org/10.1093/toxsci/kfaa036"], "rights": null, "title": "Targeted pathway-based in vivo testing using thyroperoxidase inhibition to evaluate plasma thyroxine as a surrogate metric of metamorphic success in model amphibian Xenopus laevis"}